Advertisement

Recombinant Sub-Unit and Peptide Viral Vaccines

  • F. Brown
Part of the NATO ASI Series book series (NSSA, volume 179)

Abstract

Vaccination has been such a major factor in the control of many virus diseases during the last five decades that it is often forgotten how successful vaccines have been, not only in human medicine but also in veterinary medicine. Diseases such as poliomyelitis, measles, mumps, German measles and yellow fever are now rare events in developed countries and smallpox has been eradicated from all countries of the world. In the veterinary field, foot-and-mouth disease, Newcastle disease, Marek’s disease and rinderpest are now largely controlled by vaccination.

Keywords

Tobacco Mosaic Virus Rabies Virus Newcastle Disease Peptide Vaccine Protective Immune Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderer, F.A., 1963, Versuche zur bestimmung der serologisch terminaten gruppen des tobakmosaikvirus, Z.Naturf.B., 188: 1010.Google Scholar
  2. Anderer, F.A. and Schlumberger, H.D., 1965, Properties of different artificial antigens immunologically related to tobacco mosaic virus, Biochim.Biophys.Acta, 97: 503.PubMedCrossRefGoogle Scholar
  3. Bittle, J.L., Houghten, R.A., Alexander, H., Shinnick, T.M., Sutcliffe, J.G., Lerner, R.A., Rowlands, D.J. and Brown, F., 1982, Protection against foot-and-mouth disease by immunization with a chemically synthesised peptide predicted from the viral nucleotide sequence, Nature, 298: 30.PubMedCrossRefGoogle Scholar
  4. Broekhuijsen, M.P., Blom, T., Kottenhagen, M., Pouwels, P.H., Meloen, R.H., Barteling, S.J. and Enger-Valk, B.E., 1986, Synthesis of fusion proteins containing antigenic determinants of foot-and-mouth disease virus, Vaccine, 4: 119.PubMedCrossRefGoogle Scholar
  5. Broekhuijsen, M.P., Van Rijn, J.M.M., Blom, A.J.M., Pouwels, P.H., Enger Valk, B.E., Brown, F. and Francis, M.J., 1987, Fusion proteins with multiple copies of the major antigenic determinants of foot-and-mouth disease virus protect both the natural host and laboratory animals, J. gen. Virol., 68: 3137.PubMedCrossRefGoogle Scholar
  6. Brown, F., 1984, Synthetic viral vaccines, Ann.Rev.Microbiol., 3: 221.CrossRefGoogle Scholar
  7. Clarke, B.E., Newton, S.E., Carroll, A.R., Francis, M.J., Appleyard, G., Syred, A.D., Highfield, P.E., Rowlands, D.J. and Brown, F., 1987, Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein, Nature, 330: 381.PubMedCrossRefGoogle Scholar
  8. Francis, M.J., Fry, C.M., Rowlands, D.J., Bittle, J.L., Houghten, R.A., Lerner, R.A. and Brown, F., 1987a, Immune response to uncoupled peptides of foot-and-mouth disease virus, Immunology, 61: 1.PubMedGoogle Scholar
  9. Francis, M.J., Hasting, G.A., Syred, A.D., McGinn, B., Brown, F. and Rowlands, D.J., 1987b, Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants, Nature, 330: 168.PubMedCrossRefGoogle Scholar
  10. Geysen, H.M., Meloen, R.H. and Barteling, S.J., 1984, Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid, Proc.Natl.Acad.Sci.USA, 81: 3998.PubMedCrossRefGoogle Scholar
  11. Good, M.F., Maloy, W.K., Lunde, M.N., Margalit, H., Cornette, J.L., Smith, G.L., Moss, B., Miller, L.H. and Berzofsky, J.A., 1987, Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein, Science, 235: 1059.PubMedCrossRefGoogle Scholar
  12. Kleid, D.G., Yansura, D., Small, B., Dowbenko, D., Moore, D.M., Grubman, M.J., McKercher, P.D., Morgan, D.O., Robertson, B.H. and Bachrach, H.L., 1981, Cloned viral protein vaccine for foot-and-mouth disease; Responses in cattle and swine, Science, Wash., 214: 1125.CrossRefGoogle Scholar
  13. Langebeheim, H., Arnon, R. and Sela, M., 1976, Antiviral effect on MS2 coliphage obtained with a synthetic antigen, Proc. Natl. Acad. Sci. USA, 73: 4636.CrossRefGoogle Scholar
  14. Leclerc, C., Przewlocki, G., Schutze, M. and Chedid, L., 1987, A synthetic vaccine constructed by copolymerization of B and T cell determinants, Eur.J. Immunol., 17: 269.PubMedCrossRefGoogle Scholar
  15. McAleer, W.J., Buynak, E.B., Maigetter, R.Z., Wampler, D.E., Miller, W.J. and E’Llleman, M.R., 1984, Human hepatitis B vaccine from recombinant yeast, Nature, 307: 178.PubMedCrossRefGoogle Scholar
  16. Matthews, R.E.F., 1982, Classification and nomenclature of viruses, 4th Report, Intervirology, 17: 1.CrossRefGoogle Scholar
  17. Milich, D.R. and McLachlan, A., 1986, The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen, Science, 234: 1398.PubMedCrossRefGoogle Scholar
  18. Minor, P.D., Ferguson, M., Evans, D.M.A., Almond, J.W. and Icenogle, J.P., 1986, Antigenic structure of polioviruses of serotypes 1, 2 and 3, J. gen. Virol., 67: 1283.PubMedCrossRefGoogle Scholar
  19. Morein, B. and Simons, K., 1985, Subunit vaccines against enveloped viruses; virosomes, micelles and other protein complexes, Vaccine, 2: 83.CrossRefGoogle Scholar
  20. Nurnberg, J.H., Rodgers, G., Gilbert, J.H. and Snead, R.M., 1984, Method to map antigenic determinants recognised by monoclonal antibodies: Localisation of a determinant of virus neutralization on the feline leukemia virus envelope gp70, Proc. Natl. Acad. Sci. USA, 81: 3675.CrossRefGoogle Scholar
  21. Rowlands, D.J., Clarke, B.E., Carroll, A.R., Brown, F., Nicholson, B.H., Bittle, J.L., Houghten, R.A. and Lerner, R.A., 1983, Chemical basis of antigenic variations in foot-and-mouth disease virus, Nature, 306: 694.PubMedCrossRefGoogle Scholar
  22. Strohmaier, K., Franze, R. and Adam, K-H., 1982, Localisation and characterisation of the antigenic portion of the foot-and-mouth disease virus protein, J. gen. Virol., 59: 295.PubMedCrossRefGoogle Scholar
  23. Winther, M.D., Allen, G., Bomford, R.H. and Brown, F., 1986, Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals, J. Immunol., 136: 1835.PubMedGoogle Scholar
  24. Xie, Q-C, McCahon, D., Crowther, J.R., Belsham, G.J. and McCullough, K.C., 1987, Neutralization of foot-and-mouth disease can be mediated through any of at least three separate antigenic sites, J. gen. Virol., 68: 1637.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • F. Brown
    • 1
  1. 1.Wellcome BiotechnologyLangley Court BeckenhamKentUK

Personalised recommendations